In a report released today, Alec Stranahan from Bank of America Securities maintained a Sell rating on Moderna, with a price target of $32.00. Meet Samuel – Your Personal Invest ...
Detailed price information for Coherus Oncology Inc (CHRS-Q) from The Globe and Mail including charting and trades.
Moderna Inc (NASDAQ:MRNA) shares rallied 13% over a multi-day period following reports of a localized Hantavirus outbreak aboard the cruise vessel MV Hondius.
NEW YORK - Debate over the need for COVID-19 booster shots is clouding the outlook for Moderna Inc's high-flying shares after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results